Klotho Neurosciences Inc (KLTO) USD0.0001
$0.0242
(5.27%)
- Add to watchlist
- This stock can be held in a
$0.0242
(5.27%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
$0.0242
(5.27%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
Business summary
Klotho Neurosciences, Inc. is a biopharmaceutical company. The Company is engaged in the development of disease-modifying cell and gene therapies using a patented secreted form of the anti-aging Klotho gene (s-KL) to transform the treatment of neurodegenerative and age-related disorders, such as amyotrophic lateral sclerosis (ALS), Alzheimer's, and Parkinson's disease. The Company’s portfolio consists of its proprietary cell and gene therapy programs using deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) as therapeutics and diagnostics. Its gene therapy programs include KLTO-202, KLTO-101, and KLTO-301. Other assets include clinical-stage programs involving antibody biologics targeting cancer and autoimmune diseases, and drug delivery via a needle-free dry powder jet autoinjector called Nanoject. The Company has licensed the anti-aging protein called α-Klotho for gene therapy to stop the progression of, or prevent, neurodegenerative diseases.
Contact details
Important dates
General stock information
- Short code:
- KLTO
- ISIN:
- US49876K1034
- Market cap:
- $10.49 million
- Shares in issue:
- 23.26 million
- Sector:
- Biotechnology
- Exchange:
- NASDAQ
- Country:
- United States
- Currency:
- US dollar
- Indices:
- n/a
Key personnel
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.